Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. The aim of this study was to investigate expression profile of matrix metalloproteinases (MMP-2 and MMP-9) in glottic squamous cell carcinoma (SCC) and benign vocal fold lesions (BVFLs) and to correlate it with clinical and pathological features. Methods. The immunohistochemical expression of MMP-2 and MMP-9 was investigated in specimens taken from 217 patients group, including vocal fold polyps (n=39), recurrent respiratory papillomatosis (n=30), laryngeal keratosis (n=36), glottic SCC (n=112), and the normal tissue of vocal fold (n=12, control group). The expression of MMP-2 and MMP-9, both in epithelium and stroma cells, was graded on a semiquantitative scale, ranging from 0 (no expression) to 18 points (high expression). Results. Expressions of both, MMP-2 and MMP-9 were significantly higher in the glottic SCC group comparing with BVFL group. Significant higher expression of parenchymal MMP-2 (P<0.001) and stromal MMP-9 (P=0.01) was revealed in the group of moderate/poorly differentiated glottic SCC comparing with well differentiated glottic SCC group. Expression of stroma MMP-2 was found to be correlated with nodal metastasis (P=0.030). Expressions of both, MMP-2 and MMP-9 were not correlated with clinical stage, tumor T value, smoking, alcohol use, age in the glottic SSC patients group. The MMP-2 stroma value of 11.2 points was determined as the optimum point (limiting value) for separating BVFL and glottic SCC patient groups. Conclusion. Our results suggest that expressions of both MMP-2 and MMP-9 are up-regulated already in the development of BVFL, the next determinant step is concerned with occurrence of malignization. Limiting value of stroma MMP-2 demonstrates prognostic importance of MMP-2 in glottic SCC carcinogenesis.
Abstract
Objectives. The aim of this study was to investigate expression profile of matrix metalloproteinases (MMP-2 and MMP-9) in glottic squamous cell carcinoma (SCC) and benign vocal fold lesions (BVFLs) and to correlate it with clinical and pathological features. Methods. The immunohistochemical expression of MMP-2 and MMP-9 was investigated in specimens taken from 217 patients group, including vocal fold polyps (n=39), recurrent respiratory papillomatosis (n=30), laryngeal keratosis (n=36), glottic SCC (n=112), and the normal tissue of vocal fold (n=12, control group). The expression of MMP-2 and MMP-9, both in epithelium and stroma cells, was graded on a semiquantitative scale, ranging from 0 (no expression) to 18 points (high expression). Results. Expressions of both, MMP-2 and MMP-9 were significantly higher in the glottic SCC group comparing with BVFL group. Significant higher expression of parenchymal MMP-2 (P<0.001) and stromal MMP-9 (P=0.01) was revealed in the group of moderate/poorly differentiated glottic SCC comparing with well differentiated glottic SCC group. Expression of stroma MMP-2 was found to be correlated with nodal metastasis (P=0.030). Expressions of both, MMP-2 and MMP-9 were not correlated with clinical stage, tumor T value, smoking, alcohol use, age in the glottic SSC patients group. The MMP-2 stroma value of 11.2 points was determined as the optimum point (limiting value) for separating BVFL and glottic SCC patient groups. Conclusion. Our results suggest that expressions of both MMP-2 and MMP-9 are up-regulated already in the development of BVFL, the next determinant step is concerned with occurrence of malignization. Limiting value of stroma MMP-2 demonstrates prognostic importance of MMP-2 in glottic SCC carcinogenesis.
참고문헌 (30)
- Jemal A, "Cancer statistics", CA Cancer J Clin, 57(1), pp.43~66 (2007)
- Ward EC, "Head and neck cancer: treatment, rehabilitation, and outcomes" (2007), Plural Publishing
- Rudolph E, "Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis", Eur Arch Otorhinolaryngol, 268(2), pp.165~179 (2011)
- Zhang H, "MMP-14 can serve as a prognostic marker in patients with supraglottic cancer", Eur Arch Otorhinolaryngol, 266(9), pp.1427~1434 (2009)
- Tan CT, "CXCL12", CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1, AP-1 pathway, pp.Carcinogenesis, 2008[DOI]
- Liu Y, "Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma", Acta Otolaryngol, 131(7), pp.769~773 (2011)
- 이세영, "Expression of Matrix Metalloproteinases and Their Inhibitors in Squamous Cell Carcinoma of the Tonsil and Their Clinical Significance", Clinical and Experimental Otorhinolaryngology, 4(2), pp.88~94 (2011), 대한이비인후과학회
- Vihinen P, "Matrix metalloproteinases as therapeutic targets in cancer", Curr Cancer Drug Targets, 5(3), pp.203~220 (2005)
- Sarioglu S, "Pabuccuoglu U. Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions", Pathol Res Pract, 197(7), pp.483~486 (2001)
- Bogusiewicz M, "Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer", Otolaryngol Head Neck Surg, 128(1), pp.132~136 (2003)
- Peschos D, "Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions", Histol Histopathol, 21(6), pp.603~608 (2006)
- Christopoulos TA, "Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma", Oncol Rep, 18(4), pp.855~860 (2007)
- Bartlett RS, "Genetic characterization of vocal fold lesions: leukoplakia and carcinoma", Laryngoscope, 122(2), pp.336~342 (2012)
- Liu WW, "Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis", Otolaryngol Head Neck Surg, 132(3), pp.395~400 (2005)
- Karahan N, "Matrix Metalloproteinases (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) expressions in vocal fold polyps", J Voice, 23(1), pp.29~33 (2009)
- Katayama A, "Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis", Clin Cancer Res, 10(2), pp.634~640 (2004)
- Gorogh T, "Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas", Head Neck, 28(1), pp.31~39 (2006)
- Whittaker M, "Matrix metalloproteinases and their inhibitors: current status and future challenges", Celltransmissions, 17(1), pp.3~14 (2001)
- Nelson AR, "Matrix metalloproteinases: biologic activity and clinical implications", J Clin Oncol, 18(5), pp.1135~1149 (2000)
- Danilewicz M, "Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer", Med Sci Monit, 9(3), pp.MT42~MT47 (2003)
- Jodele S, "Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression", Cancer Metastasis Rev, 25(1), pp.35~43 (2006)
- Wittekindt C, "Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas", Acta Otolaryngol, 131(1), pp.101~106 (2011)
- Hanata K, "Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts", Arch Histol Cytol, 70(5), pp.267~277 (2007)
- Xie M, "Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases", Laryngoscope, 114(12), pp.12243~2248 (2004)
- Roepman P, "Multiple robust signatures for detecting lymph node metastasis in head and neck cancer", Cancer Res, 66(4), pp.2361~2366 (2006)
- Yuce I, "The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma", Am J Otolaryngol, 32(2), pp.141~146 (2011)
- Mallis A, "Papadas TA. MMP-2 expression in 102 patients with glottic laryngeal cancer", Eur Arch Otorhinolaryngol, 269(2), pp.639~642 (2012)
- Ruokolainen H, "Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis", Clin Cancer Res, 10(9), pp.3110~3116 (2004)
- Kosunen A, "CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma", Oral Oncol, 43(1), pp.51~59 (2007)
- Sun Y, "Role of siRNA silencing of MMP-2 gene on invasion and growth of laryngeal squamous cell carcinoma", Eur Arch Otorhinolaryngol, 265(11), pp.1385~1391 (2008)